Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors

NCT04640480 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Breast Cancer
Pancreas Cancer
Ovarian Cancer
Small-cell Lung Cancer
Gastric Cancer
Head and Neck Cancer

Interventions

DRUG: SNB-101

Sponsor

SN BioScience